Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
2004 1
2005 2
2007 1
2011 2
2012 1
2014 1
2015 1
2017 1
2020 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
The association between sunshine duration and paroxetine response time in patients with major depressive disorder.
Tomita T, Yasui-Furukori N, Nakagami T, Kaneda A, Kaneko S. Tomita T, et al. J Affect Disord. 2012 Feb;136(3):1067-71. doi: 10.1016/j.jad.2011.11.012. Epub 2011 Dec 6. J Affect Disord. 2012. PMID: 22153922
RESULTS: The responses to paroxetine treatment of the group that began treatment in fall and winter and of the group that began treatment in spring and summer did not differ significantly. The effect of the duration of monthly sunshine on paroxetine response time di …
RESULTS: The responses to paroxetine treatment of the group that began treatment in fall and winter and of the group that began treatment in …
Paroxetine response and tolerability among ethnic minority patients with mood or anxiety disorders: a pooled analysis.
Roy-Byrne PP, Perera P, Pitts CD, Christi JA. Roy-Byrne PP, et al. J Clin Psychiatry. 2005 Oct;66(10):1228-33. doi: 10.4088/jcp.v66n1004. J Clin Psychiatry. 2005. PMID: 16259535
METHOD: A pooled analysis of 14,875 adults who participated in 104 double-blind, placebo-controlled paroxetine clinical trials investigating major depression, panic disorder, generalized anxiety disorder, social anxiety disorder, obsessive-compulsive disorder, posttraumati …
METHOD: A pooled analysis of 14,875 adults who participated in 104 double-blind, placebo-controlled paroxetine clinical trials invest …
Cardiac autonomic tone, plasma BDNF levels and paroxetine response in newly diagnosed patients of generalised anxiety disorder.
Dutt R, Shankar N, Srivastava S, Yadav A, Ahmed RS. Dutt R, et al. Int J Psychiatry Clin Pract. 2020 Jun;24(2):135-142. doi: 10.1080/13651501.2020.1723642. Epub 2020 Feb 5. Int J Psychiatry Clin Pract. 2020. PMID: 32022607
Objective: The study examined the effect on cardiac autonomic tone via heart rate variability (HRV), brain derived neurotrophic factor (BDNF) in newly diagnosed generalised anxiety disorder (GAD) cases with paroxetine-controlled release (PX) CR intervention.Methods: Fifty GAD cas …
Objective: The study examined the effect on cardiac autonomic tone via heart rate variability (HRV), brain derived neurotrophic factor (BDNF …
The efficacy of paroxetine and placebo in treating anxiety and depression: a meta-analysis of change on the Hamilton Rating Scales.
Sugarman MA, Loree AM, Baltes BB, Grekin ER, Kirsch I. Sugarman MA, et al. PLoS One. 2014 Aug 27;9(8):e106337. doi: 10.1371/journal.pone.0106337. eCollection 2014. PLoS One. 2014. PMID: 25162656 Free PMC article.
METHODS AND FINDINGS: GlaxoSmithKline has been required to post the results for all sponsored clinical trials online, providing an opportunity to assess the efficacy of an SSRI (paroxetine) with a complete data set of all trials conducted. ...Overall change in placebo-trea …
METHODS AND FINDINGS: GlaxoSmithKline has been required to post the results for all sponsored clinical trials online, providing an op …
Biological profiling of prospective antidepressant response in major depressive disorder: Associations with (neuro)inflammation, fatty acid metabolism, and amygdala-reactivity.
Mocking RJT, Nap TS, Westerink AM, Assies J, Vaz FM, Koeter MWJ, Ruhé HG, Schene AH. Mocking RJT, et al. Psychoneuroendocrinology. 2017 May;79:84-92. doi: 10.1016/j.psyneuen.2017.02.019. Epub 2017 Feb 21. Psychoneuroendocrinology. 2017. PMID: 28262603
PURPOSE: To test (I) alterations in (neuro)inflammation and its associations with fatty acid metabolism and amygdala-reactivity in MDD-patients compared to controls, and (II) whether these alterations are associated with prospective paroxetine response. METHODS: We …
PURPOSE: To test (I) alterations in (neuro)inflammation and its associations with fatty acid metabolism and amygdala-reactivity in MDD-patie …
A controlled trial of paroxetine for chronic PTSD, dissociation, and interpersonal problems in mostly minority adults.
Marshall RD, Lewis-Fernandez R, Blanco C, Simpson HB, Lin SH, Vermes D, Garcia W, Schneier F, Neria Y, Sanchez-Lacay A, Liebowitz MR. Marshall RD, et al. Depress Anxiety. 2007;24(2):77-84. doi: 10.1002/da.20176. Depress Anxiety. 2007. PMID: 16892419 Clinical Trial.
Significantly more patients treated with paroxetine were rated as responders (14/21, 66.7%) on the Clinical Global Impression-Improvement Scale (CGI-I) compared to patients treated with placebo (6/22, 27.3%). ...Paroxetine was also superior to placebo on reduction of disso …
Significantly more patients treated with paroxetine were rated as responders (14/21, 66.7%) on the Clinical Global Impression-Improve …
Fatty acid metabolism and its longitudinal relationship with the hypothalamic-pituitary-adrenal axis in major depression: Associations with prospective antidepressant response.
Mocking RJ, Verburg HF, Westerink AM, Assies J, Vaz FM, Koeter MW, Ruhé HG, Schene AH. Mocking RJ, et al. Psychoneuroendocrinology. 2015 Sep;59:1-13. doi: 10.1016/j.psyneuen.2015.04.027. Epub 2015 May 11. Psychoneuroendocrinology. 2015. PMID: 26010860 Clinical Trial.
After 6 weeks, we continued this treatment in responders (i.e. showing 50% decrease in Hamilton depression rating scale-score), and randomized non-responders to a 6-week, double-blind, placebo-controlled dose-escalation up to 50mg/day. ...CONCLUSIONS: FA-metabolism alterat …
After 6 weeks, we continued this treatment in responders (i.e. showing 50% decrease in Hamilton depression rating scale-score), and rando …
A mathematical model for paroxetine antidepressant effect time course and its interaction with pindolol.
Gruwez B, Dauphin A, Tod M. Gruwez B, et al. J Pharmacokinet Pharmacodyn. 2005 Dec;32(5-6):663-83. doi: 10.1007/s10928-005-0006-6. J Pharmacokinet Pharmacodyn. 2005. PMID: 16307210
The model was applied to the simulation of paroxetine response (clinical score) time course with or without pindolol, after administration of different doses of each drug. The simulated total scores on the MADR scale obtained after treatment with paroxetine a …
The model was applied to the simulation of paroxetine response (clinical score) time course with or without pindolol, a …
11 results